Support WBUR

FDA approves Alzheimer's drug that appears to modestly slow disease

04:01

Jon Hamilton

Updated January 06, 2023

U.S. health officials approved Leqembi, a new Alzheimer's drug that modestly slows the brain disease. The FDA granted accelerated approval Friday for patients in early stages of Alzheimer's. (AP)

This article was originally published on January 06, 2023.

Is lecanemab the Alzheimer's drug that will finally make a difference?
Study: Alzheimer's drug shows modest success slowing declines in memory, thinking
What causes Alzheimer's? Study puts leading theory to 'ultimate test'

Support WBUR